| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5833047 | International Immunopharmacology | 2013 | 7 Pages |
Abstract
⺠Sorafenib is a multi-kinase inhibitor approved for cancer treatment. ⺠We examine the immunomodulatory effect of sorafenib on macrophages. ⺠Sorafenib induces autophagy and alters functions of human macrophages.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jiunn-Chang Lin, Chien-Liang Liu, Jie-Jen Lee, Tsan-Pai Liu, Wen-Chin Ko, Yu-Chuen Huang, Chih-Hsiung Wu, Yu-Jen Chen,